Abstract: Chaperone-mediated autophagy (CMA) is involved in wild-type α-synuclein degradation in Parkinson's disease (PD), and LAMP2A and Hsc 70 have recently been indicated to be deregulated by microRNAs. To recognize the regularory role of miR-320a in CMA and the possible role in α-synuclein degradation, in the present study, we examined the targeting and regulating role of miR-320 in Hsc 70 expression. We first constructed an α-synuclein-overexpressed human neuroblastoma cell line, SH-SY5Y-Syn(+), stably over-expressing wild-type α-synuclein and sensitive to an autophagy inhibitor, which exerted no effect on the expression of LAMP2A and Hsc 70. Then we evaluated the influence on the CMA by miR-320a in the SH-SY5Y-Syn(+) cells. It was shown that miR-320a mimics transfection of specifically targeted Hsc 70 and reduced its expression at both mRNA and protein levels, however, the other key CMA molecule, LAMP2A was not regulated by miR-320a. Further, the reduced Hsc 70 attenuated the α-synuclein degradation in the SH-SY5Y-Syn(+) cells, and induced a significantly high level of α-synuclein accumulation.
roles in the α-synuclein aggregation in PD [40] [41] [42] , and the CMA-associated LAMP-2A and Hsc 70 are regulated during the microRNA-mediated α-synuclein degradation via CMA.
In the present study, we first constructed an α-synuclein-overexpressed human neuroblastoma cell line, SH-SY5Y-Syn(+) to evaluate the regulation by miR-320a on the CMA and their influence on the α-synuclein degradation. It was shown that miR-320a mimics transfection specifically targeted Hsc 70 and reduced its expression in both mRNA and protein levels, and the reduced Hsc 70 promoted a significantly high level of α-synuclein accumulation. This study supports the hypothesis that elevated miRNA levels in Parkinson's disease brains will lead to reduced CMA and result in reduced CMA-mediated α-synuclein degradation. Therefore, drugs that intervene with miRNAs, which silence CMA function in PD might be a way to modify impaired α-synuclein degradation in brains.
Results

Construction of SH-SY5Y Cells Over-Expressing α-Synuclein
To explore the influence of CMA-targeted microRNAs on the α-synuclein degradation, we firstly established an SH-SY5Y cell line over-expressing wild-type α-synuclein, SH-SY5Y-Syn(+). Wild-type α-Syn coding sequence was amplified and cloned into a pcDNA3.1(+) vector. Stable α-Syn-over-expressed SH-SY5Y-Syn(+) cells were selected and maintained in complete medium containing 300 μg/mL G418, post the α-Syn-pcDNA3.1(+) transfection. A significantly higher and stable level of α-Syn mRNA was observed in the SH-SY5Y-Syn(+) cells post various passages than normal SH-SY5Y cells (t-test, p < 0.01 respectively) ( Figure 1A ). The α-Syn expression in protein level was also upregulated in the SH-SY5Y-Syn(+) cells (p < 0.05 for t-test, or p < 0.01 for ANOVO test, respectively) ( Figure 1B,C) , revealed by western blot analysis. On the other side, to confirm whether there was an influence on the expression of CMA-associated molecules, we also examined the expression of Hsc 70 and LAMP2A in protein levels by western blot assay; it was shown in Figure 1B ,D that there was no significant difference in the expression of the two molecules between SH-SY5Y-Syn(+) cells and normal SH-SY5Y cells.
SH-SY5Y-Syn(+) Cells Are Sensitive to Autophagy Inhibitors
To investigate whether the SH-SY5Y-Syn(+) cell line is qualified to evaluate the α-Syn degradation by autophagy, we exposed the SH-SY5Y-Syn(+) cells to optimal concentrations of chloroquine (50 or 100 μM) or E64D (50 or 100 μg/mL) for 48 h, both of which inhibits the autophagic protein degeneration, by blocking lysosome fusion (chloroquine) [43] or inhibiting lysosomal protease (E64D) [44] . Neither drug significantly affected LAMP2A or Hsc 70 expression in protein level (Figure 2A ,B) or in mRNA levels ( Figure 2C ) in the SH-SY5Y-Syn(+) cells. The α-Synuclein protein levels in the SH-SY5Y-Syn(+) cells significantly increased post the chloroquine or E64D treatment, by western blot analysis (p < 0.05 for t-test, or p < 0.01 for ANOVO test respectively) ( Figure 2D ,E). To determine whether the α-Syn increase in transcription was induced, we also determined the α-Syn expression at the mRNA level by reverse transcription reactions and quantitative polymerase chain reactions (RT-qPCR) method. And Figure 2F demonstrated that the α-Syn upregulation in protein level was not associated with increased α-synuclein mRNA levels post chloroquine or E64D treatment.
Therefore, SH-SY5Y-Syn(+) cells were sensitive to chemical inhibitors on autophagic degeneration, which had no regulation on the endogenous CMA-associated molecules, LAMP2A and Hsc 70. 
miRNA-320a Targets and Reduces Hsc 70 Expression in SH-SY5Y-Syn(+) Cells
It has been implied that miRNA-320a is highly paired to the 3' UTR or Hsc 70 in neuronal cells [42] . In order to confirm the deregulation of miRNA-320a on Hsc 70 expression and its influence on α-Syn degradation, we evaluated the expression of Hsc 70, LAMP2A and α-Syn accumulation in the SH-SY5Y-Syn(+) cells. We found that the miRNA-320a was highly paired to three sites at the 3' UTR or Hsc 70 by miRTarBase analysis ( Figure 3A ). Then we elevated the miRNA-320a level in the SH-SY5Y-Syn(+) cells by transfection of miRNA-320a mimics. Figure 3B indicated a significantly high level of miR-320a in the cells post 20 or 40 nM miRNA-320a mimics transfection, compared to the miRNA control group (either p < 0.001). Moreover, the miRNA-320a mimics transfection could significantly downregulate the α-Syn level in mRNA level (p < 0.05 for 20 nM and p < 0.01 for 40 nM) ( Figure 3C ) and in protein level (p < 0.05 for 20 nM and p < 0.01 for 40 nM) ( Figure 3D ,E). However, the expression of the other important CMA molecule, LAMP2A was not influenced by the miRNA-320a mimics transfection (Figure 3D ,F,G). The experiments were performed separately in triplicate. Statistical significance was shown as * p < 0.05, ** p < 0.01, *** p < 0.01, ns, no significance.
miR-320a Mimics Inhibited α-Synuclein Degradation in SH-SY5Y-Syn(+) Cells
To further explore the influence of Hsc 70 knockdown by miR-320a on the α-synuclein aggregation, we determined the influence of miR-320a mimics or miRNA control transfection on the α-synuclein aggregation. It was indicated that neither 20, nor 40 nM miR-320a mimics transfection significantly regulated the α-synuclein expression in mRNA level ( Figure 4A ), compared to the miRNA control. However, the western blot assay revealed that the miR-320a mimics significantly induced a high level of α-synuclein aggregation in the SH-SY5Y-Syn(+) cells, with a dose-dependence and time-dependence, there was significant difference in groups with different miR-320a mimics concentration (p < 0.05 for t-test, p < 0.01 for ANOVA test, respectively) ( Figure 4B,C) . To confirm that the α-synuclein aggregation was only caused by CMA blockage, we further determined the autophagy-associated molecules, LC3-I/II and Atg 5. It was shown in Figure 4D ,E that the conversion of LC3-I to LC3-II, and the expression of Atg 5 was not influenced by the miR-320a transfection, compared to the miRNA control (p > 0.05, respectively). Thus, we have identified the promotion of miR-320a to the α-synuclein aggregation in the α-synuclein overexpressing SH-SY5Y cells, by inhibiting the Hsc 70-mediated CMA.
Discussion
Sporadic PD is pathologically characterized with α-synuclein aggregation and formation of LBs. However, the biochemical abnormality responsible for the disease remains to be defined. Compared to familial PD, which is believed to be caused by the multiplication of the α-synuclein locus and increased α-synuclein synthesis [8] , sporadic PD is normal in α-synuclein synthesis, whereas it is deficient in α-synuclein degradation, which leads to α-synuclein accumulation and aggregation [45, 46] . And there is a consensus that α-synuclein aggregation is predominantly caused by impaired CMA [10, 19] . Up to now, there are many reports focusing on the impaired α-synuclein degradation by CMA. On one side, various α-synuclein mutations and modifications including oxidative damage and S129 phosphorylation [47, 48] lead to the blockage of α-synuclein degradation. On the other side, the deregulated CMA-associated LAMP2A and Hsc 70 have been confirmed in PD brains [10] . Further, α-synuclein aggregation is reported to be a consequence of impaired degradation by CMA [42] .
Recent studies have reported, the influence of miRNAs on the various neurodegenerative disorders including Alzheimer's disease [37] and Parkinson disease [49] via post-transcriptional regulation of protein levels. In PD, significant changes in the miRNA expression profile have been reported with numerous miRNA precursors elevated in the midbrain [40] . And some of these miRNAs, such as miR-26b, miR-106a and miR-301b (targeting Hsc 70), or miR-21, miR-224 and miR-373 (targeting LAMP2A) have been confirmed to target the 3' UTR of either Hsc 70 or LAMP2A [42] . And miR-320a was also indicated to target the 3' UTR of LAMP2A. However, miR-320a had no influence on the expression of endogenous LAMP-2A in normal SHSY5Y cells, and the luciferase reporter assay reconfirmed that miR-320a had no regulation on the 3' UTR of LAMP-2A [42] . In the present study, we firstly constructed an α-synuclein-over-expressed human neuroblastoma cell line, SH-SY5Y-Syn(+), which stably over-expressed α-synuclein, whereas the expression of CMA-associated Hsc 70 and LAMP2A had not been influenced by the over-expressed α-synuclein. Moreover, the SH-SY5Y-Syn(+) cells were sensitive to autophagy inhibitor, E64D and chloroquine; treatment with E64D or chloroquine significantly induced α-synuclein accumulation in the SH-SY5Y-Syn(+) cells, whereas the CMA-associated Hsc 70 and LAMP2A were not regulated by the over-expressed α-synuclein or the both agents. Thus, the α-synuclein-over-expressed human neuroblastoma cell line was qualified to evaluate the regulation by miRNAs on the CMA and their influence on the α-synuclein degradation. Then we screened miRNAs which targeted Hsc 70 or LAMP2A with miRTAR, and it was shown that miR-320a targeted the 3' UTR of Hsc 70. The significantly elevated miR-320a level by miR-320a mimics transfection specifically reduced the expression of Hsc 70 at both the mRNA and protein levels. Further, the reduced level of Hsc 70 by miR-320a mimics transfection attenuated the α-synuclein degradation in the SH-SY5Y-Syn(+) cells. The present study demonstrates for the first time that miR-320a targeted the 3' UTR of Hsc 70, and attenuated the role of Hsc 70 in the α-synuclein degradation. It implies that miR-320a might be involved in α-synuclein aggravation in PD.
Materials and Methods
Reagents, Cell Culture and Treatment
SH-SY5Y cells (human neuroblastoma cell line) purchased from ATCC were cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, CA, USA) containing 10% FBS (Invitrogen, Carlsbad, CA, USA) or maintained in DMEM supplemented with 2% FBS. E64D and chloroquine were purchased from Sigma-Aldrich (St. Louis, MO, USA) and were resolved in DMEM medium supplemented with 2% FBS. To generate an α-synuclein overexpressed cell line, the wild α-synuclein coding sequence was amplified and cloned into the multiple cloning sites between BamH I and Hind III of pcDNA3.1(+) vector. And SH-SY5Y cells were transfected with the α-Syn-pcDNA3.1(+) or control pcDNA3.1(+) vectors, and were selected in the presence of 0.5 mg/mL G418. miR-320a mimics or miRNA control (GenePharma, Shanghai, China) with a concentration of 20 or 40 nM was transfected with lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) into the SH-SY5Y cells to promote the miR-320a level.
RNA Isolation, Reverse Transcription, Reverse Transcription Reactions and Quantitative Polymerase Chain Reactions (RT-qPCR)
Total cellular RNA was isolated with PureLink ® RNA Mini Kit (Invitrogen, Carlsbad, CA, USA), and miRNAs was isolated using mirVana™ miRNA Isolation Kit (Ambion, Austin, TX, USA) according to manuals. The expression of α-Syn, Hsc 70, LAMP2A or β-actin in mRNA level was quantified by the real-time RT-PCR method with Takara One Step RT-PCT kit (Takara, Tokyo, Japan). The primers for α-Syn, Hsc 70, LAMP2A or β-actin were as follows: PF-Hsc70: 5'-TGCTGCTGCTATTGCTTACG-3', PR-Hsc70: 5'-TCAATAGTGAGGATTGACACATCA-3'; PF-Lamp2a: 5'-GTCTCAAGCGCCATCA TACT-3', PR-Lamp2a: 5'-TCCAAGGAGTCTGTCTTAAGTAGC-3'; PF-β-actin: 5'-AAGGACTCCT ATAGTGGGTGACGA-3', PR-β-actin: 5'-ATCTTCTCCATGTCGTCCCAGTTG-3'; PF-α-Syn: 5'-AGG ACTTTCAAAGGCCAAGG-3', PR-α-Syn: 5'-TCCTCCAACATTTGTCACTTGC-3'. miRNAs were isolated using mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA). RT-qPCR were performed using the MicroRNA TaqMan Reverse Transcription Kit and the TaqMan MicroRNA Assays (Applied Biosystems, Foster City, CA, USA) for mir-320a. mRNA or miRNA samples were amplified using primer sets specific for the genes of interest on a Lightcycler 480 II (Roche Diagnostics, GmbH, Germany). Relative quantification was determined using the ∆∆Ct method using β-actin or U6 as reference gene [50] .
Western Blot Analysis
Cell samples were lysed with cell lysis reagent (Promega, Madison, WI, USA) and quantified using BCA Protein Assay Reagent Kit (Pierce, Rockford, IL, USA), protein samples were separated by a 12% gradient SDS-PAGE gel, transferred to polyvinylidene fluoride membrane. Then the blotted membrane was blocked with 5% milk and respectively incubated with the rabbit polyclonal antibody to Hsc 70 (Abcam, Cambridge, UK), LAMP2A (Abcam, Cambridge, UK), α-synuclein (Santa Cruz Biotechnology, Santa Cruz, CA, USA), LC3-I/II (Sigma-Aldrich, St. Louis, MO, USA), Atg 5 (Sigma-Aldrich, St. Louis, MO, USA) or β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by incubation with horseradish peroxidase-coupled secondary antibody (Cell Signaling Technology, Inc., Danvers, MA, USA). The proteins were detected using enhanced chemiluminescence (Thermo Scientific, Rockford, IL, USA). All immunoblots are representative of at least three independent experiments.
Statistical Evaluation
All data are presented as mean ± SE. For the expression analysis of Hsc 70, LAMP2A, α-synuclein, LC3-I/II, Atg 5 in mRNA or protein levels, or miR-320a between two groups, statistical evaluations are presented as mean ± SE. Data were analyzed using the Student's t-test, and the statistical difference among more than two groups, data were analyzed using multivariate ANOVA test. A statistical significance was considered when p < 0.05. Statistical analyses were performed using SPSS 16.0 software (IBM SPSS, Inc., Chicago, IL, USA) according to the software manual.
Conclusions
In conclusion, we demonstrated that miR-320a specifically targeted the 3' UTR of Hsc 70, decreased Hsc 70 expression at both the protein and mRNA levels in an α-synuclein-over-expressed SH-SY5Y cells, and resulted in significant α-synuclein intracellular accumulation. The present study for the first time indicates that miR-320a targeted the 3' UTR of Hsc 70, and attenuated the role of Hsc 70 in the α-synuclein degradation. It implies that the miR-320a might be involved in α-synuclein aggravation in PD.
